-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2022.
- Horizon Therapeutics Public Ltd Co Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $58.1M, a 22.9% increase year-over-year.
- Horizon Therapeutics Public Ltd Co Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $193M, a 5.99% decline year-over-year.
- Horizon Therapeutics Public Ltd Co annual Share-based Payment Arrangement, Expense for 2022 was $182M, a 16.9% decline from 2021.
- Horizon Therapeutics Public Ltd Co annual Share-based Payment Arrangement, Expense for 2021 was $219M, a 49.4% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Share-based Payment Arrangement, Expense for 2020 was $147M, a 60.7% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)